Amgen's Upcoming Presentation at a Prestigious Healthcare Conference
Amgen (NASDAQ: AMGN) is gearing up to make a significant appearance at the annual Morgan Stanley Global Healthcare Conference, scheduled to take place soon. The conference highlights the most innovative firms in the healthcare sector, where Amgen will share insights that reflect its commitment to improving patient care through remarkable medical advancements.
Conference Details
This important event will feature Amgen's executive vice president and chief financial officer, Peter Griffith, alongside Kave Niksefat, senior vice president of Global Marketing and Access. They are set to present the company’s latest developments and elaborate on strategies that have shaped Amgen's progress in biotechnology.
The discussion is scheduled for 9:15 a.m. ET. As an addition, a live webcast will be available for viewers, allowing both investors and the general public to tune in and hear directly from Amgen leadership about ongoing efforts and outcomes in the biotech landscape.
Webcast Availability
The webcast of this conference will be discoverable on Amgen's official website, specifically in the Investors section. Those interested are encouraged to check the Investor Relations Events Calendar for updates on presentation timings and subsequent webinar access. Notably, the recorded session will remain accessible for viewing long after the live event, ensuring that everyone can benefit from the insights shared.
Exploring Amgen's Impact
Amgen has excelled in the biotechnology domain for more than four decades, continually striving to develop groundbreaking therapies that cater to patients grappling with formidable health challenges. The company's ingenuity has been instrumental in treating diseases across various categories, including cancer, osteoporosis, and cardiovascular conditions.
This commitment to innovation led to Amgen being recognized as one of the "World's Most Innovative Companies" and one of "America's Best Large Employers. This recognition underscores Amgen's stature not only as a trailblazer in medicine but also as an employer of choice in the biotech sector.
About Amgen
Amgen is dedicated to discovering, developing, manufacturing, and delivering cutting-edge medicines designed to make a difference in the lives of patients worldwide. The company’s approach combines advanced technology with insights derived from human genetics to create powerful therapies that help combat diverse health issues.
As a proud constituent of the Dow Jones Industrial Average and the Nasdaq-100 Index, Amgen stands amongst the most significant and innovative players on the stock market. This prestige highlights Amgen's influential role in shaping health care through continuous advancements in science and technology.
Staying Connected with Amgen
For those eager to learn more about the company's journey and its latest updates, visiting Amgen's official website is a great starting point. Engaging with Amgen through various social platforms—like X (formerly Twitter), LinkedIn, and Instagram—offers additional avenues for staying informed about their ongoing innovations, announcements, and community engagements.
Frequently Asked Questions
What is the purpose of the Morgan Stanley Healthcare Conference?
The conference showcases leading companies in the healthcare sector, providing them with a platform to share insights and developments with investors and the public.
Who from Amgen will be presenting at the conference?
The presentation will feature Peter Griffith, the CFO, and Kave Niksefat, the Senior Vice President of Global Marketing and Access.
How can I access the conference webcast?
The webcast will be available on Amgen's official website in the Investors section, allowing the public to watch the event live and replay it later.
What accolades has Amgen received recently?
Amgen has been named one of the "World's Most Innovative Companies" and one of "America's Best Large Employers," reflecting its innovative approaches and employee satisfaction.
What therapeutic areas does Amgen focus on?
Amgen's research and development efforts target areas including cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases.
